Cargando…
Variability in total serum IgE over 1 year in severe asthmatics
BACKGROUND: Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgE(tot)) in asthmatics remains poorly documented. METHODS: In this prospective study, sIgE(tot) levels wer...
Autores principales: | Louis, Renaud, Pilette, Charles, Michel, Olivier, Michils, Alain, Brusselle, Guy, Poskin, Antoine, Van Schoor, Jan, Denhaerynck, Kris, Vancayzeele, Stefaan, Abraham, Ivo, Gurdain, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441212/ https://www.ncbi.nlm.nih.gov/pubmed/30976287 http://dx.doi.org/10.1186/s13223-019-0331-8 |
Ejemplares similares
-
Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study
por: Rakic, Jean-Marie, et al.
Publicado: (2013) -
Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
por: Graff, S., et al.
Publicado: (2020) -
Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020) -
COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
por: Hanon, Shane, et al.
Publicado: (2020) -
The prevalence of IgE-dependent food allergy in asthmatic children
por: Krogulska, A, et al.
Publicado: (2013)